DK0410953T3 - Piperidinforbindelser - Google Patents

Piperidinforbindelser

Info

Publication number
DK0410953T3
DK0410953T3 DK90870119.6T DK90870119T DK0410953T3 DK 0410953 T3 DK0410953 T3 DK 0410953T3 DK 90870119 T DK90870119 T DK 90870119T DK 0410953 T3 DK0410953 T3 DK 0410953T3
Authority
DK
Denmark
Prior art keywords
carbon atoms
optionally substituted
radicals
piperidine
alkaryl
Prior art date
Application number
DK90870119.6T
Other languages
English (en)
Inventor
Daniel Paul Getman
Crescenzo Gary Anthony De
Original Assignee
Monsanto Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/386,538 external-priority patent/US5025021A/en
Priority claimed from US07/400,252 external-priority patent/US5026713A/en
Application filed by Monsanto Co filed Critical Monsanto Co
Application granted granted Critical
Publication of DK0410953T3 publication Critical patent/DK0410953T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/42—Oxygen atoms attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/22—Tin compounds
    • C07F7/2224—Compounds having one or more tin-oxygen linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK90870119.6T 1989-07-27 1990-07-23 Piperidinforbindelser DK0410953T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/386,538 US5025021A (en) 1989-07-27 1989-07-27 1,2-dideoxy-2-fluoronojirimycin as glycosidase inhibitors
US07/400,252 US5026713A (en) 1989-08-29 1989-08-29 1,3-dideoxy-3-fluoronojirimycin which inhibits glycosidase activity

Publications (1)

Publication Number Publication Date
DK0410953T3 true DK0410953T3 (da) 1996-01-22

Family

ID=27011478

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90870119.6T DK0410953T3 (da) 1989-07-27 1990-07-23 Piperidinforbindelser

Country Status (8)

Country Link
EP (1) EP0410953B1 (da)
JP (1) JPH0358969A (da)
AT (1) ATE129997T1 (da)
CA (1) CA2022061A1 (da)
DE (1) DE69023408T2 (da)
DK (1) DK0410953T3 (da)
ES (1) ES2036512T3 (da)
GR (1) GR3018629T3 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5128347A (en) * 1990-10-18 1992-07-07 Monsanto Company Glycosidase inhibiting 1,4-dideoxy-4-fluoronojirimycin
EP0566557B1 (en) * 1992-04-01 1996-09-04 G.D. SEARLE & COMPANY 2- and 3- amino and azido derivatives of 1,5-iminosugars as antiviral compounds
US5258518A (en) * 1992-04-01 1993-11-02 G. D. Searle & Co. 2-substituted tertiary carbinol derivatives of deoxynojirimycin
US5268482A (en) * 1992-04-01 1993-12-07 G. D. Searle & Co. 2- and 3-sulfur derivatives of 1,5-iminosugars
US5451679A (en) * 1994-03-08 1995-09-19 G. D. Searle & Co. 2-chloro and 2-bromo derivatives of 1,5-iminosugars
JPH10502093A (ja) * 1994-07-27 1998-02-24 ジェンザイム・リミテッド レジオ選択的硫酸化

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3611841A1 (de) * 1986-04-09 1987-10-15 Bayer Ag Verfahren zur herstellung von 1-desoxynojirimycin und dessen n-derivaten
DE3722788A1 (de) * 1987-07-10 1989-01-19 Bayer Ag Chirale 6-hydroxymethylenverzweigte 3-amino-4,5-dihydroxypiperidine, zwischenprodukte zu ihrer herstellung, verfahren zu ihrer herstellung und ihre verwendung

Also Published As

Publication number Publication date
EP0410953A3 (en) 1991-08-21
DE69023408D1 (de) 1995-12-14
EP0410953B1 (en) 1995-11-08
ES2036512T1 (es) 1993-06-01
GR3018629T3 (en) 1996-04-30
ES2036512T3 (es) 1996-03-01
ATE129997T1 (de) 1995-11-15
JPH0358969A (ja) 1991-03-14
CA2022061A1 (en) 1991-01-28
EP0410953A2 (en) 1991-01-30
DE69023408T2 (de) 1996-05-02

Similar Documents

Publication Publication Date Title
DE69020287D1 (de) Pleuromutiline.
ATE90358T1 (de) Zwischenprodukte in der synthese von diaminandrostan-derivaten.
DK0826688T3 (da) Pentacykliske forbindelser
DK345989D0 (da) Quinolinderivater
DE69728544D1 (de) Totalsynthese von acylfulvenen mit antitumorwirkung
FI952101A0 (fi) Merkaptanfoerening
DE69104593D1 (de) Herstellung und Verwendung von N-Jodopropargyl-oxycarbonylaminosäure-Estern als antimicrobielle Mittel.
ATE93232T1 (de) Bis(methylendioxy)biphenyl-verbindungen.
DE69001495D1 (de) Dioxaphosphorin-verbindungen und damit stabilisierte polyolefin-zusammensetzungen.
ATE129997T1 (de) Glykosidasehemmende piperidinverbindungen.
FI914526A0 (fi) Foerening, dess framstaellning och anvaendning.
ES2005192A6 (es) Procedimiento para la fabricacion de un derivado de 1,5-diofenil-ih-1,2,4-triazol-3-carboxamida.
FI914525A0 (fi) Foerening, anvaendning och framstaellning.
DE3879058D1 (de) 4-piperidincarboxamid-derivate.
DE3664467D1 (de) Pineapple ketone l'alkoxyalkyl derivatives
ES469096A1 (es) Un procedimiento para la preparacion dos sustancialmente insolubles en agua.
ATE189813T1 (de) Prostaglandin-i-analoga
ATE100449T1 (de) 1,3-dioxolan-benzoesaeure und derivate davon.